Why is lithium [not] the drug of choice for bipolar disorder? a controversy between science and clinical practice.
Journal Information
Full Title: Int J Bipolar Disord
Abbreviation: Int J Bipolar Disord
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Declarations Ethics approval and consent to participateNot applicable. Competing interestsLVK has within the preceding three years been a consultant for Lundbeck and Teva. Competing interests LVK has within the preceding three years been a consultant for Lundbeck and Teva."
Funding Disclosure
Evidence found in paper:
"Funding Open access funding provided by Copenhagen University."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025